KR960704933A - 난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도 - Google Patents

난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도

Info

Publication number
KR960704933A
KR960704933A KR1019960701447A KR19960701447A KR960704933A KR 960704933 A KR960704933 A KR 960704933A KR 1019960701447 A KR1019960701447 A KR 1019960701447A KR 19960701447 A KR19960701447 A KR 19960701447A KR 960704933 A KR960704933 A KR 960704933A
Authority
KR
South Korea
Prior art keywords
pain
relaxin
analgesic
intractable pain
mitigating agent
Prior art date
Application number
KR1019960701447A
Other languages
English (en)
Inventor
브라이언 시드
존 씨. 시드
Original Assignee
브라이언 시드
존 씨. 시드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브라이언 시드, 존 씨. 시드 filed Critical 브라이언 시드
Publication of KR960704933A publication Critical patent/KR960704933A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

본 발명은 동통 치료용 약물의 제조에의 릴렉신의 용도 및 릴렉신을 포유동물에 투여하는 과정을 포함하는 포유동물의 동통 경감 방법에 관계한다.

Description

난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 릴렉신을 포유동물에 투여하는 과정을 포함하는 포유동물의 동통 경감 방법.
  2. 제1항에 있어서, 상기 동통이 만성적인 것인 방법.
  3. 제1항에 있어서, 상기 동통이 상기 포유동물 조직의 확장, 종창, 또는 탈구로부터 결과되는 방법.
  4. 제1항에 있어서, 상기 동통이 만성 후부 동통인 방법.
  5. 제1항에 있어서, 상기 동통이 종양 동통인 방법.
  6. 제1항에 있어서, 상기 동통이 의인성 동통인 방법.
  7. 제1항에 있어서, 상기 동통이 관절염 관절 동통인 방법.
  8. 제1항에 있어서, 상기 동통이 분만후 골반 관절 동통인 방법.
  9. 동통 치료용 약물의 제조에의 릴렉신의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960701447A 1993-09-29 1994-09-26 난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도 KR960704933A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/128,912 1993-09-29
US08/128,912 US5656592A (en) 1993-09-29 1993-09-29 Use of relaxin as an analgesic and palliative for intractable pain
PCT/US1994/010867 WO1995009184A1 (en) 1993-09-29 1994-09-26 Use of relaxin as an analgesic and palliative for intractable pain

Publications (1)

Publication Number Publication Date
KR960704933A true KR960704933A (ko) 1996-10-09

Family

ID=22437587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960701447A KR960704933A (ko) 1993-09-29 1994-09-26 난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도

Country Status (10)

Country Link
US (1) US5656592A (ko)
EP (1) EP0721467B1 (ko)
JP (1) JPH09503208A (ko)
KR (1) KR960704933A (ko)
AT (1) ATE211920T1 (ko)
AU (1) AU7958694A (ko)
DE (2) DE69429664T2 (ko)
ES (1) ES2097100T3 (ko)
PT (1) PT721467E (ko)
WO (1) WO1995009184A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434777T2 (de) * 1993-07-27 2007-06-14 Mario Bigazzi Verwendung von Relaxin zur Herstellung von therapeutischer Mittel
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US6719977B1 (en) 1998-02-12 2004-04-13 The General Hospital Corporation Methods to potentiate cancer therapies
WO1999040929A1 (en) * 1998-02-12 1999-08-19 The General Hospital Corporation Methods to potentiate cancer therapies
DE1145189T1 (de) 1998-08-14 2002-04-18 3M Innovative Properties Co ANWENDUNGEN FüR RF-IDENTIFIZIERUNGSSYSTEME
ES2344741T3 (es) * 1998-08-14 2010-09-06 3M Innovative Properties Company Lector de rfid.
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
US6984128B2 (en) * 2002-11-01 2006-01-10 Bas Medical, Inc. Methods for enabling and stabilizing tooth movement
CN104888182A (zh) * 2015-07-07 2015-09-09 韩军 一种治疗产后腹痛的中药制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656249A (en) * 1982-06-10 1987-04-07 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
US5145962A (en) * 1982-08-12 1992-09-08 Howard Florey Institute Of Experimental Physiology And Medicine Human pro relaxin polypeptides
US5179195A (en) * 1982-12-13 1993-01-12 Howard Florey Institute Of Experimental Physiology And Medicine Human relaxin polypeptides

Also Published As

Publication number Publication date
DE721467T1 (de) 1997-06-26
ES2097100T1 (es) 1997-04-01
US5656592A (en) 1997-08-12
ES2097100T3 (es) 2002-08-01
ATE211920T1 (de) 2002-02-15
EP0721467A4 (en) 1998-04-22
AU7958694A (en) 1995-04-18
EP0721467B1 (en) 2002-01-16
WO1995009184A1 (en) 1995-04-06
JPH09503208A (ja) 1997-03-31
DE69429664T2 (de) 2002-08-14
PT721467E (pt) 2002-05-31
DE69429664D1 (de) 2002-02-21
EP0721467A1 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
NO960445D0 (no) Hudplaster og fremgangsmåter for å administrere testosteron
HU9700056D0 (en) New pharmaceutical composition for treating pains
EP0802782A4 (en) PROPHYLACTIC AND THERAPEUTIC TREATMENT OF MAIN SENSITIZATION AND IRRITATION
KR890700349A (ko) 피임 및 유방암 억제용 조성물 및 이의 제조방법
SG54210A1 (en) Oral composition for the treatment of bowel inflammatory bowel diseases
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
AU6848098A (en) Use of misoprostol or/and misoprostol acid for preparing drug in order to cu re erectile dysfunction
KR960704933A (ko) 난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도
ZA973444B (en) Transdermally administered dextromethorphan as antitussive agents.
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
KR900005974A (ko) 남성의 성기능 장애 치료제
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
NO20003510D0 (no) Fett-bindende polymerer
HUT70521A (en) Process to prepare pharmaceutical comps. again amyloidosis
KR890007728A (ko) 진통제 제조방법
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
SE8804640L (sv) Laekemedel omfattande cyklolinopeptide a
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
SE9700617D0 (sv) New composition
DK0678027T3 (da) Antiatherosclerotiske midler
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application